Does early diagnosis of idiopathic pulmonary fibrosis matter? Real-world's data from the EMPIRE registry

• Authors: VAŠÁKOVÁ Martina; STERCLOVA Martina; KUS Jan; BARTOS Vladimir; HAJKOVA Marta; DOUBKOVÁ Martina; MULLER Veronika; PLACKOVA Martina; ZURKOVA Monika; LOSTAKOVA Vladimira; LACINA Ladislav; RIHAK Vladimir; PETRIK Frantisek; LISÁ Pavlina; BITTENGLOVA Radka; JOVANOVIC Dragana; TYL Richard; ONDREJKA Gustav; SULDOVA Hana; LNENICKA Jaroslav; PSIKALOVA Jana; SNIZEK Tomas; HOMOLKA Jiri; KRALOVA Renata; KERVITZER Jan; SVOBODA Michal; STRENKOVÁ Jana
• Year of publication: 2016
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: AIMS: Idiopathic pulmonary fibrosis (IPF) is a severe lung disease with mean survival of 2.5 years. Delay in diagnosis and treatment probably decreases a survival in IPF. Our study aims to investigate influence of time from the first symptoms to diagnosis on the survival. CONCLUSIONS: Our results show that earlier diagnosis and treatment may increase survival in IPF. Early diagnosis and treatment does matter in prognosis of IPF patients and thus maximal effort should be generated to get the patients diagnosed and treated as early as possible.